Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00020960
DRKS00020960
Completed
Not Applicable

Personalized Risk Prediction in Coronary Artery Disease - PRECAD

Deutsches Herzzentrum München der Technischen Universität0 sites1,400 target enrollmentApril 20, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCoronary artery diseaseI25Chronic ischaemic heart disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary artery disease
Sponsor
Deutsches Herzzentrum München der Technischen Universität
Enrollment
1400
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Deutsches Herzzentrum München der Technischen Universität

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients 18 years of age or older
  • •2\. Informed, written consent by the patient
  • •3\. Coronary angiogram showing one of the following:
  • •\- coronary three vessel disease, or
  • •\- coronary two vessel disease, or
  • •\- exclusion of relevant coronary lesions

Exclusion Criteria

  • •1\. Acute myocardial infarction
  • •2\. Cardiogenic shock, haemodynamic instability
  • •3\. Active bleeding or clinically important anemia (i.e. \<7g/dl)
  • •4\. Participation in an investigational drug or device study in the last 30 days
  • •5\. Pregnancy or lactation
  • •6\. Any other severe comorbidity such as active cancer with life expectancy less than 12 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
cardiovascular risk prediction as per prakriti
CTRI/2024/05/067087Chaudhary Brahm Prakash ayurved Charak Sansthan
Recruiting
Not Applicable
The New predictiVe factors that drIve coronary atheroscleroSIs follOwiNg Coronary Artery Disease (VISION-CAD)” studyCoronary artery diseaseAtherosclerosisIschaemic heart diseaseCardiovascularCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemCardiovascular - Coronary heart disease
ACTRN12623000458639South Australian Health and Medical Research Institute300
Active, not recruiting
Phase 1
Cardiovascular (CV) risk prediction and CV biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors (CNI)Open randomized 12 month study
EUCTR2013-001178-20-SEppsala University Hospital, MHT, Department of Nephrology105
Active, not recruiting
Phase 1
Cardiovascular (CV) risk prediction and CV biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors (CNI)Open randomized 12 month studyProphylaxis of graft rejection in adults who have received a renal transplantMedDRA version: 20.0Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000022818Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2013-001178-20-DKppsala University Hospital, MHT, Department of Nephrology110
Active, not recruiting
Phase 1
Does conversion to Nulojix reduce the risk of cardiovascular disease in kidney transplant recipients?Prophylaxis of graft rejection in adults who have received a renal transplantMedDRA version: 17.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000004865Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2013-001178-20-NLppsale University Hospital, MHT, Department of Nephrology105